Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> ABBVIE Latest News

JAN 23, 2015 - TheStreet

A Must Read - Share

10 Stocks Billionaire John Paulson Loves: DirecTV, AbbVie and More

      NEW YORK (Stockpickr) -- At Stockpickr, we track the top holdings of a variety of high-profile investors, such as George Soros and Carl Icahn. Must Read: Warren Buffett's Top 10 Dividend Stocks One of the most popular of these portfolios is that of Paulson & Co., run by John Paulson, No. 84 on Forbes' list of the ...

Tags: 10 Stocks Billionaire John Paulson Loves: DirecTV, AbbVie and More,  Abbvie Latest News

JAN 22, 2015 - TheStreet

A Must Read - Share

11 Dividend Stocks Buffett, Soros and Other Billionaires Love

NEW YORK (TheStreet) -- For income-seeking investors, it's a tricky time. Plummeting oil prices are pushing many energy companies toward a breaking point (Lightstream Resources  and Linn Energy  have already moved to slash dividends), and while utilities continue to look stable, there are only so many stocks to go around. What's an investor to do? Try looking to billionaire investors ...

Tags: 11 Dividend Stocks Buffett, Soros and Other Billionaires Love,  Abbvie Latest News

JAN 21, 2015 - Benzinga

A Must Read - Share

Deutsche Bank Comments On Concerns Over Consensus Estimates For AbbVie And Gilead Sciences

Deutsche Bank commented on AbbVie Inc (NYSE: ABBV) and Gilead Sciences, Inc. (NASDAQ: GILD) Wednesday and felt that consensus may be too high on both companies. Latest Ratings for ABBV DateFirmActionFromTo Jan 2015BarclaysMaintainsOverweight Jan 2015JefferiesMaintainsBuy Jan 2015Bank of AmericaDowngradesBuyNeutral View More Analyst Ratings for ABBV View the Latest Analyst Ratings

Tags: Deutsche Bank Comments On Concerns Over Consensus Estimates For AbbVie And Gilead Sciences,  Abbvie Latest News

JAN 21, 2015 - Zacks Investment Research

A Must Read - Share

Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog

The hepatitis C virus (HCV) pricing battle is heating up with Gilead (GILD) signing on with quite a few PBMs and health care benefit companies for Sovaldi and Harvoni.

Tags: Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog,  Abbvie Latest News

JAN 20, 2015 - Business Insider

A Must Read - Share

STOCKS EKE OUT GAINS: Here's What You Need To Know (DIA, SPY, QQQ, TLT, OIL, USO, BHI, OPCO, UL, IBM, XHB, OWW, MS)

Stocks eked out gains on Tuesday after spending much of the day in negative territory, though stocks managed to move into positive territory in the final couple hours of trading. Last week, stocks gained ground only one time and finished lower for the fourth straight week. First, the scoreboard: Dow: 17,515.2, +3.6, (+0.02%) S&P 500: 2,022.5, +3.1, (+0.1%) Nasdaq: 4,654.8, ...

Tags: STOCKS EKE OUT GAINS: Here's What You Need To Know (DIA, SPY, QQQ, TLT, OIL, USO, BHI, OPCO, UL, IBM, XHB, OWW, MS),  Abbvie Latest News